Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid, Adrenaline, and Bupivacaine for Pain and Healing in Split-Thickness Skin Graft Donor Sites
TCTR20250208007Phase 3Completed
- Sponsor
- Nakornping Hospital
- Start
- May 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tranexamic acid, epinephrine and bupivacaine in Surgical wound (2 arms), sponsored by Nakornping Hospital. Started May 2023; status: completed.
02
Drugs
tranexamic acidepinephrinebupivacaine
03
Conditions
Surgical wound
Beyond the preview
Go deeper on TCTR20250208007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250208007.